Controlled Substances
Opioids
For more information, see pain control
Benzodiazepines
General information
Include benzodiazepine receptor agonists, e.g. zolpidem (Ambien), zaleplon (Sonata), eszopiclone (Lunesta)
Effectively treat generalized/social anxiety, panic disorder, sleep disorders when prescribed at low doses for a short period of time (< 30 days)
Choosing wisely: Don’t use benzodiazepines or other sedative-hypnotics in older adults as first choice for insomnia, agitation, or delirium
Risks
Risks while driving: Same as BAC between 0.050% and 0.079%
Long term use: Substantial cognitive decline that did not resolve 3 months after discontinuation
May be appropriate for seizure disorders, rapid eye movement sleep disorders, benzodiazepine withdrawal, ethanol withdrawal, severe generalized anxiety disorder, periprocedural anesthesia, end-of-life care
Avoid benzodiazepines (any type) for treatment of insomnia, agitation, or delirium due to increase risk of cognitive impairment, delirium, falls, fractures, and motor vehicle accidents (SOR Strong)
Benzodiazepine-receptor agonists
Adverse events are similar to those of benzodiazepines in older adults
Avoid chronic use, i.e. > 90 days (SOR Strong)
Agents with Primary Care Prescribing Suggestions
Use
Anxiety: Benzodiazepines are NOT first line (SSRIs, SNRIs are)
Insomnia: Effect diminishes after a few weeks
Seizure disorder: Should be managed by neurology
Start taper for any patient taking daily benzodiazepines for > 1 month, especially:
Age > 65 years
If also taking opioids or amphetamines
In patients with history of a substance abuse, cognitive disorder, and/or TBI
Codes
Code A - Panic Disorder
Code B - Behavior/Attention Deficit
Code C - Chronic Debilitation/Neurological Disorder/Seizures etc
Code D - Chronic pain/Incurable
Code E - Narcolepsy
Code F - Hormone Deficiency/Metastatic Breast Cancer